CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −14,968 | 293,963 | ||
| 2023-05-03 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +16,149 | $0.04 | $646 | 349,346 |
| 2023-05-03 | Doerfler Douglas President and CEO | Sale 10b5-1 | −16,149 | $5.02 | $81K | 333,197 |
| 2023-05-03 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −16,149 | 308,931 | ||
| 2023-04-12 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +5,583 | $2.14 | $12K | 5,583 |
| 2023-04-12 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −5,583 | $5.00 | $28K | 0 |
| 2023-04-12 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,583 | 13,868 | ||
| 2023-04-12 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +12,718 | $0.04 | $509 | 345,915 |
| 2023-04-12 | Doerfler Douglas President and CEO | Sale 10b5-1 | −12,718 | $5.00 | $64K | 333,197 |
| 2023-04-12 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −12,718 | 325,080 | ||
| 2023-04-11 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +8,451 | $2.14 | $18K | 8,451 |
| 2023-04-11 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −8,451 | $5.00 | $42K | 0 |
| 2023-04-11 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,451 | 19,451 | ||
| 2023-04-11 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +2,182 | $0.04 | $87 | 335,379 |
| 2023-04-11 | Doerfler Douglas President and CEO | Sale 10b5-1 | −2,182 | $5.00 | $11K | 333,197 |
| 2023-04-11 | Doerfler Douglas President and CEO | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,182 | 337,798 | ||
| 2023-04-10 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise 10b5-1 | +100 | $2.14 | $214 | 100 |
| 2023-04-10 | Ross Thomas M. EVP, Global Sales & Marketing | Sale 10b5-1 | −100 | $5.00 | $500 | 0 |
| 2023-04-10 | Ross Thomas M. EVP, Global Sales & Marketing | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −100 | 27,902 | ||
| 2023-04-10 | Doerfler Douglas President and CEO | Option exercise 10b5-1 | +100 | $0.04 | $4 | 333,297 |
Page 12 of 15 · 282 trades